Tang Yingying, Guo Xiongfeng, Yan Mengqi, Xu Cenglin
Department of Pharmacy, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, 310006, China.
Key Laboratory of Neuropharmacology and Translational Medicine of Zhejiang Province, School of Pharmaceutical Science, Zhejiang Chinese Medical University, Hangzhou, 310053, Zhejiang, China.
Acta Epileptol. 2024 Oct 25;6(1):29. doi: 10.1186/s42494-024-00174-3.
Unprovoked seizures in early life are one of the most severe conditions in pediatric neurology, and are often associated with long-lasting cognitive and behavioral deficits, as well as pharmacoresistant epilepsy in adulthood in some conditions. Unillustrated mechanisms greatly restrict the development of preventive strategies for early-life seizures (ELSs) related neuronal impairments. The recent groundbreaking study published in The Journal of Clinical Investigation represents a giant leap forward in understanding the complex pathogenesis mechanism and developing targeted therapies for ELS related neuronal impairments. The authors conducted elegant experiments to locate the activated pyramidal neuron subpopulation in the hippocampus and demonstrated the altered functions of (α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid)-type glutamate receptors (AMPARs). And we believe that the conclusions of this study may assist in further translational efforts to identify preventive targets for neurological disorders associated with early life seizures and propose new avenues for further exploration in this field.
早年发生的无诱因癫痫发作是小儿神经病学中最严重的病症之一,在某些情况下,常伴有长期的认知和行为缺陷以及成年期药物难治性癫痫。尚不明确的机制极大地限制了针对早年癫痫发作(ELS)相关神经元损伤的预防策略的发展。发表在《临床研究杂志》上的这项最新的开创性研究在理解复杂的发病机制以及开发针对ELS相关神经元损伤的靶向治疗方面向前迈出了巨大的一步。作者进行了精细的实验来定位海马体中被激活的锥体神经元亚群,并证明了α-氨基-3-羟基-5-甲基-4-异恶唑丙酸(AMPA)型谷氨酸受体(AMPARs)功能的改变。我们相信,这项研究的结论可能有助于进一步开展转化研究,以确定与早年癫痫发作相关的神经系统疾病的预防靶点,并为该领域的进一步探索提出新的途径。